Chemfab Alka. (CHEMFAB)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Let me examine Chemfab Alka the way I would any business. First, I look for earnings power. Here I find none: the latest quarter shows a net loss of ₹4 Cr on sales of ₹68 Cr, and annual profit growth has collapsed by 336.70%. With sales down 18.51%, the business is shrinking, not compounding. A P/E of 0.00 is not cheap; it is a warning that earnings have disappeared. Graham taught me that price is what you pay, value is what you get. At ₹398.45, I am being asked to pay 1.44 times book value of ₹275.99 for a company earning only 2.48% ROE and 3.32% ROCE. That return is below what a fixed deposit could give me, and it carries business risk on top. The Piotroski F-Score of 3 out of 9 further suggests weak financial health. I do see some positives: debt-to-equity of 0.29 is moderate, and promoter holding of 72.13% means insiders have skin in the game. But skin in the game is not the same as a durable moat. This is commodity chemicals; there is no pricing power unless you are the lowest-cost producer, and the falling sales and losses say Chemfab is not in that position today. The dividend yield of 0.33% is too small to compensate shareholders while they wait. The 52-week range of ₹290.35 to ₹764.00 shows how volatile this stock has been, but I am not interested in catching a falling knife. In my circle of competence, I want businesses with consistent profitability, clear competitive advantages, and management that creates value. Chemfab Alka currently fails these tests. It may be a cyclical company near the bottom, but I do not need to gamble on a turnaround. I would rather watch from the sidelines and wait for evidence of sustainable earnings before calculating any intrinsic value.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer